Goodbody Health Limited (Previously: Goodbody Health Inc.) Director Transfer of Ordinary Shares
Goodbody Health Limited (AQSE:GDBY) announced the transfer of 200,000 ordinary shares by Executive Chairman Geremy Thomas to an unrelated party for nil consideration on August 30, 2022. Following this transaction, Thomas holds 7,640,638 ordinary shares, representing approximately 20.94% of the company's issued share capital. The company emphasizes that forward-looking statements made in the release are subject to significant risks and uncertainties, which may materially affect future results.
- Geremy Thomas retains a significant interest, holding approximately 20.94% of the company's issued share capital after the transfer.
- None.
ST. PETER PORT, GUERNSEY / ACCESSWIRE / August 30, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), today announces that Geremy Thomas, the Executive Chairman and Director of the Company transferred 200,000 ordinary shares to an unrelated party for nil consideration on August the 30th 2022. Post this transaction Geremy Thomas has an interest in 7,640,638 ordinary shares, representing approximately
The directors of the Company accept responsibility for the contents of this announcement
Cautionary Statement Regarding Forward-Looking Statements
This press release contains certain forward-looking statements. These statements are identified by the use of the words "project," "believe," "estimate," "expect," "anticipate," "intend," "contemplate," "foresee," "would," "could," "plan," and similar expressions that are intended to identify forward-looking statements, which are generally not historical in nature. These forward- looking statements are based on management's current expectations and beliefs concerning future developments and their potential effect on Goodbody. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting Goodbody will be those that are anticipated. All comments concerning the Company's expectations for future revenues and operating results are based on the Company's estimates for its existing operations and do not include the potential impact of any future acquisitions. Goodbody's forward-looking statements involve significant risks and uncertainties (some of which are beyond Goodbody's control) and assumptions that could cause actual results to differ materially from Goodbody's historical experience and present expectations or projections. Known material factors that could cause actual results to differ materially from those in the forward-looking statements include:. You are cautioned not to place undue reliance on forward-looking statements contained in this press release, which speak only as of the date of this press release. Forward-looking statements also are affected by the risk factors described in Goodbody's filings with the British Columbia Securities Commission. Goodbody undertakes no obligation to publicly update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise.
On behalf of the Board of Directors,
Contact Information:
Marc Howells | Anne Tew |
SOURCE: Goodbody Health Limited
View source version on accesswire.com:
https://www.accesswire.com/714006/Goodbody-Health-Limited-Previously-Goodbody-Health-Inc-Director-Transfer-of-Ordinary-Shares
FAQ
What was announced in the Goodbody press release on August 30, 2022?
What percentage of shares does Geremy Thomas hold after the August 30, 2022 transaction?
What is the stock symbol for Goodbody Health Limited?
